Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
RVXCF
Primary Symbol:
T.RVX
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Jan 24, 2022 12:18pm
Dr. M. Sweeney interview on CHQR!
Somewhat of a waste of time. Too deep for the layperson imo. The Dr. I think has C19 based on his inability to stop a throat cough. Should have taken a rapid test before the studio setting. Too
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Jan 23, 2022 10:56am
COVID-19 antiviral treatment arrives in Nova Scotia.
Pfizer's Paxlovid will first be offered to the most vulnerable in the province! As for me,,,,no more boosters unless we get a deadly vairiant of C19. Had the three shots in <year and still we
...more
Discover Options Trading Strategies to Minimize your Tax Burden
posted Nov 30, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 22, 2022 7:54am
RE:RE:Canadian Covid pill potential Edmonton Journal Jan 18, 2022
QT,,,,,,you cant be serious,,,,,,why would any shareholder take DMcC at his word,,,,,,good grief,,this man has absolutley no idea around research protocol or what takes place during a trial or for
...more
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Jan 21, 2022 10:22pm
RE:Canadian Covid pill potential Edmonton Journal Jan 18, 2022
"McCaffrey said the drug is affordable as well, with each pill costing around $7. He said patients would take two pills a day for a couple of weeks, a month at most. If the testing phase goes
...more
(1)
•••
doosomdo
X
View Profile
View Bullboard History
Post by
doosomdo
on Jan 21, 2022 3:51pm
Link : Med info on gouv Canada site
https://covid-vaccine.canada.ca/info/paxlovid-en.html
(1)
•••
doosomdo
X
View Profile
View Bullboard History
Post by
doosomdo
on Jan 21, 2022 3:42pm
Paxlovid approv. by Health Canad, lots of med not compatible
I'm at home on isolation because of contact with someone infected by Covid and assymptmatic! 2 of the meds that I was taking last summer are on the list of meds not recommended with Paxlovid
...more
(1)
•••
doosomdo
X
View Profile
View Bullboard History
Post by
doosomdo
on Jan 21, 2022 1:54pm
Canadian Covid pill potential Edmonton Journal Jan 18, 2022
RVX.T Published in Edmonton Journal Jan 18th, 2022 go view for full article but here are some broad lines… An Alberta-developed drug heralded as a potential oral treatment for
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Jan 21, 2022 7:54am
Pfizer's COVID-19 pill could have real impact....
...in Canada — if we can roll it out fast enough!!!!,,,,,,News headline!!!! https://www.cbc.ca/news/health/pfizer-pill-paxlovid-canada-covid-19-rollout-hospitalization-1.6318097 After Canada
...more
(3)
•••
seanj1
X
View Profile
View Bullboard History
Comment by
seanj1
on Jan 21, 2022 2:21am
RE:RE:RE:RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
Since this is an open label trial with short duration, if there is a positive outcome it will surely leak out and we will see that in sp and volume before any announcements from the company. I hope
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 20, 2022 3:33pm
RE:RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
,,,,,Hummmm........just a thought,,,,, but,,,,if there is leakage of a Lazarus effect,,,,I think we will have a chance of seeing the CUP being requested!,,,,that would be a great indication to the
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 20, 2022 5:37am
RE:RE:RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
Hummmmm,,welll,,its been 48 hours since we were first notified dosing had started with trial patients,,,,,I will assume the johnny shirts are off and the street clothes are on those not on placebo!!!&
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 19, 2022 8:26am
RE:RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
Purdy well on the mark sj1,,,,,,,however if they accidentally do get good numbers in any form we might get a bump up in share price........I see a few media outlets have picked up the C19 dosing story
...more
(3)
•••
seanj1
X
View Profile
View Bullboard History
Comment by
seanj1
on Jan 19, 2022 2:19am
RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
They are going to mess up the study... as long as McCaffrey is in charge, market will not trust the company and what it says. Hence the sp lack of action..
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 18, 2022 6:45pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Interference
GV,,,,,,lets hope is right,,,,,,the market is not putting any speculation into this company because of its inability to prove and provide sharevalue these past 20 years. Nothing will move the share
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >